Results 11 to 20 of about 5,030 (176)

Exploring the advancements of Australian OPAT

Therapeutic Advances in Infectious Disease, 2023
Outpatient parenteral antimicrobial therapy (OPAT) in Australia has evolved from modest beginnings to a well-established health service with proven benefits in patient outcomes.
Tony Lai, Horst Thiele, Benjamin A. Rogers, Nadine Hillock, Suman Adhikari, Alexander McNamara, Matthew Rawlins   +6 more
doaj   +2 more sources

From sea to shining IV: the current state of OPAT in the United States

Therapeutic Advances in Infectious Disease, 2023
First described in the United States, outpatient parenteral antibiotic therapy (OPAT) has become an indispensable part of treating serious infections. The proportion of infectious disease (ID) physicians utilizing a formal OPAT program has increased in ...
Jeffrey Larnard, Kyleen Swords, Dan Taupin, Simi Padival   +3 more
doaj   +2 more sources

Palliative outpatient parenteral antimicrobial therapy (OPAT): A single center experience and systematic scoping review [PDF]

Clinical Infection in Practice, 2022
Traditionally, outpatient parenteral antimicrobial therapy (OPAT) is used to treat infections with predictable course and anticipated response to therapy. However, there has been little consideration of OPAT for palliation as opposed to cure.
Oyewole Chris Durojaiye, Ihsan Jibril, Evangelos I Kritsotakis   +2 more
doaj   +2 more sources

Clinical Outcomes of Piperacillin/Tazobactam Treatment in Outpatient Parenteral Antimicrobial Therapy (OPAT) Programs: Comparison of Two Models of Opat Care

Pharmaceutics
Objectives: Piperacillin/tazobactam (P/T) is a broad-spectrum β-lactam antibiotic frequently used in outpatient parenteral antimicrobial therapy programs (OPAT). We aim to compare the clinical outcomes of P/T treatment in two models of OPAT care in order
Santiago J. Lora-Escobar, Laura Herrera-Hidalgo, Nerea Castillo-Fernández, Zaira R. Palacios-Baena, Rafael Luque-Márquez, Arístides De Alarcón, Ana Belén Guisado-Gil, Belén Gutierrez-Gutierrez, María Dolores Navarro-Amuedo, Julia Praena-Segovia, Marta Mejías Trueba, Juan Manuel Carmona-Caballero, José Manuel Sánchez Oliva, María Victoria Gil-Navarro, Luis E. López-Cortés   +14 more
doaj   +2 more sources

Outpatient parenteral antimicrobial therapy (OPAT) for aortic vascular graft infection; a five-year retrospective evaluation

BMC Infectious Diseases, 2021
Objectives An estimated 1% of endovascular aneurysm repair (EVAR) devices become infected, carrying a high mortality rate. Surgical explantation is recommended and prognosis is guarded. This retrospective cohort analysis focuses on the role of outpatient
Niamh Allen, Mohamed Adam, Grace O’Regan, Aoife Seery, Cora McNally, Samuel McConkey, Aisling Brown, Eoghan de Barra   +7 more
doaj   +2 more sources

Continuous Intravenous Acyclovir as Outpatient Parenteral Antimicrobial Therapy for HSV and VZV Neurological Infections: A Case Series With Pharmacokinetic and Cost Evaluation, and Review of Literature. [PDF]

Rev Med Virol
ABSTRACT Varicella zoster virus (VZV) and herpes simplex virus (HSV) are major causes of viral meningitis and encephalitis. Standard intermittent intravenous acyclovir requires hospitalisation, reducing patient comfort and prolonging admissions. Continuous infusion may maintain therapeutic plasma and cerebrospinal fluid (CSF) concentrations while ...
Manders IG, van Tuinen EL, Weisfelt M, Goeijenbier M, Kalpoe JS, van Lelyveld SFL, van Gorp ECM, Hua KH.   +7 more
europepmc   +2 more sources

Literature review and case report on the use of rezafungin for spondylodiscitis in an outpatient parenteral antimicrobial therapy (OPAT) setting. [PDF]

J Bone Jt Infect
Richards AJ, Asif A, Ivan M, Lillie PJ, Barlow G, Walsh C.   +5 more
europepmc   +3 more sources

Patients referred to but not taken on to an outpatient parenteral antimicrobial therapy (OPAT) service: the impact of infection specialist advice on the assessment and clinical outcomes. [PDF]

JAC Antimicrob Resist
Rimbi M, Pybus S, Dodds S, White B, Ritchie N, Seaton RA.   +5 more
europepmc   +2 more sources

Outpatient Parenteral Antimicrobial Therapy for Pseudomonas aeruginosa Infections: Effectiveness and Safety [PDF]

Pharmaceutics
Objective: Given the increasing use of outpatient parenteral antimicrobial therapy (OPAT) and the clinical challenges posed by Pseudomonas aeruginosa infections, this study aimed to evaluate the effectiveness and safety of OPAT for the treatment of P ...
Paloma Suárez-Casillas, Marta Mejías-Trueba, Iris Martínez Alemany, Lola Navarro Amuedo, Julia Praena Segovia, Arístides de Alarcón González, Rafael Luque Márquez, Zaira R. Palacios-Baena, Juan Manuel Carmona-Caballero, José Manuel Sánchez Oliva, María Victoria Gil-Navarro, Manuel García Gutiérrez, Laura Herrera-Hidalgo, Manuel Poyato Borrego, Luis E. López-Cortés, José M. Cisneros   +15 more
doaj   +2 more sources

A novel meropenem dosing strategy for Outpatient Parenteral Antimicrobial Therapy (OPAT): a pilot pharmacokinetic/pharmacodynamic study in non-critically ill patients. [PDF]

Antimicrob Agents Chemother
Briquet C, Ngougni Pokem P, Liu X, Wijnant G-J, Cornu O, Yildiz H, Verroken A, Roberts JA, Yombi JC, Van Bambeke F.   +9 more
europepmc   +2 more sources